At the Two-Year Mark, the Clock is Ticking On the I3C as LSID Spec Gains Traction | GenomeWeb

Two years ago this month, Sun Microsystems announced the first plans for an industry-wide consortium to develop and promote open standards for interoperability in the life sciences. Now, the Interoperable Informatics Infrastructure Consortium, or I3C, has reached a critical point in its development: Even as its first reference implementation, the Life Science Identifier, is being adopted in some key bioinformatics resources, criticism of the group’s direction and doubts about its chances of success continue to spread unabated throughout the life science community.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.